ProShare Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.2M | Sell |
|
|||||
|
2024
Q4 | $1.24M | Buy |
|
|||||
|
2024
Q3 | $792K | Buy |
|
|||||
|
2024
Q2 | $414K | Sell |
|
|||||
|
2024
Q1 | $419K | Buy |
|
|||||
|
2023
Q4 | $496K | Buy |
|
|||||
|
2023
Q3 | $339K | Sell |
|
|||||
|
2023
Q2 | $285K | Buy |
|
|||||
|
2023
Q1 | $277K | Sell |
|
|||||
|
2022
Q4 | $282K | Buy |
|
|||||
|
2022
Q3 | $307K | Sell |
|
|||||
|
2022
Q2 | $292K | Sell |
|
|||||
|
2022
Q1 | $444K | Sell |
|
|||||
|
2021
Q4 | $473K | Buy |
|
|||||
|
2021
Q3 | $297K | Sell |
|
|||||
|
2021
Q2 | $615K | Sell |
|
|||||
|
2021
Q1 | $693K | Buy |
|
|||||
|
2020
Q4 | $616K | Buy |
|
|||||
|
2020
Q3 | $238K | Sell |
|
|||||
|
2020
Q2 | $249K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $191K | Buy |
|
|||||
|
2019
Q3 | $191K | Buy |
|
|||||
|
2019
Q2 | $149K | Sell |
|
|||||
|
2019
Q1 | $160K | Buy |
|
|||||
|
2018
Q4 | $177K | Sell |
|
|||||
|
2018
Q3 | $205K | Sell |
|
|||||
|
2018
Q2 | $251K | Buy |
|
|||||
|
2018
Q1 | $240K | Sell |
|
|||||
|
2017
Q4 | $296K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $87K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $58K | Sell |
|
|||||
|
2014
Q4 | $34K | Sell |
|
|||||
|
2014
Q3 | $57K | Sell |
|
|||||
|
2014
Q2 | $73K | Sell |
|
|||||
|
2014
Q1 | $235K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $53K | Buy |
|
|||||
|
2013
Q2 | $55K | Buy |
|